UroGen’s shares drop 20% as the FDA raises concerns about the trial design for UGN-102 bladder cancer treatment.

Tenbucksixer concert: 6 p.m., Bootstrap Brewing Company, 142 Pratt St., Longmont. Tenbucksixer is an original band with ...

Jonathan Cohen and Sarah Leff got together a group of 14 designers for a three-day New York pop-up, in a bid to engage ...

The US Food and Drug Administration has approved an at-home cervical cancer screening tool as an alternative to Pap smears by ...

The first trial of CarPlay Ultra in an Aston Martin has deemed Apple's in-car upgrade a massive success, even if car ...

As M&S navigates the fallout of a cyber-attack, Drapers speaks with crisis management experts on how the retailer has handled ...

U.S. President Donald Trump was set to meet Syria's president in Saudi Arabia on Wednesday following a surprise announcement ...

Q1 2025 Earnings Call Transcript May 13, 2025 Intellicheck, Inc. beats earnings expectations. Reported EPS is $-0.02, ...

Canva never ceases to amaze with its innovative features, and the latest addition, Canva Sheets, is no exception. Canva ...

Canton Fire Department paramedic Timothy Nuttall shows how to do a Carotid Pulse at Karen Read's second murder trial at ...

"Although treatment with stimulants has been found to be effective at reducing ADHD symptoms in children and adolescents, ...

The FDA has approved the first at-home cervical cancer screening device, designed to make women feel more comfortable with ...